Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

2,3-naphthalocyanine

Known as: Si(IV)-naphthalocyanine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Using X-ray as the irradiation source, a photodynamic therapy process can be initiated from under deep tissues. This technology… Expand
2015
2015
The effects of seven macrocyclic compounds comprising four phthalocyanines (Pcs) namely 1,4,8,11,15,18,22,25-octabutoxy-29H,31H… Expand
  • figure 1
  • figure 1
  • figure 2
  • figure 2
  • figure 2
2008
2008
Soluble precursors of 2,3-naphthalocyanine (Nc) and phthalocyanine (Pc) were prepared and were converted into insoluble… Expand
Highly Cited
2001
Highly Cited
2001
Up to eight redox-active ferrocenyl units have been incorporated, through the unsaturated ethynyl linkers, on the periphery of a… Expand
1997
1997
A Si(IV)-naphthalocyanine bearing two methoxyethylenglycol axial ligands to the centrally coordinated metal ion (SiNc) was… Expand
Highly Cited
1994
Highly Cited
1994
Bis(tert-butyldimethylsiloxy)- (7), bis(dimethylthexylsiloxy)- (8), bis(tri-n-hexylsiloxy)- (9), and bis(dimethyloctadecylsiloxy… Expand
1994
1994
The possibility of extending photodynamic therapy to the treatment of highly pigmented neoplastic lesions was tested by using Si… Expand
1994
1994
A diode laser with roughly 480 mW/cm2 emission at 776 nm was developed and engineered to obtain a uniform illumination of tumour… Expand
1992
1992
A water-soluble derivative of the highly hydrophobic molecule Si(IV)-naphthalocyanine was synthesized by the addition of two… Expand
Highly Cited
1990
Highly Cited
1990
The pharmacokinetic behaviour and phototherapeutic effectiveness of bis(di-isobutyloctadecylsil-oxy)-2,3-naphthalocyanatosilicon… Expand
  • figure 1
  • table I
  • table II
  • figure 2
  • table III